Please Enter a Search Term

Joy McCarthy

M.D. Memorial, FRCP(C)

Clinical Associate Professor of Oncology (Medical Oncology)

Dr. H. Bliss Murphy Cancer Centre
300 Prince Phillip Dr.
St. John's, NL  A1B 3V6

t: (709)777-7436
f: (709) 777-8756

Dr. Joy McCarthy is a Medical Oncologist and Division Chief of Medical Oncology with the Cancer Care Program of Eastern Health in St. John’s, NL.  She is a Clinical Associate Professor within the Discipline of Oncology, Memorial University of Newfoundland.  Dr. McCarthy completed her Medical Degree at Memorial University of Newfoundland in 1996 and her certifications in Internal Medicine in 2000 and Medical Oncology in 2001.  
Dr. McCarthy is a member of the Beatrice Hunter Cancer Research Institute, CAMO, ASCO, CCTG, Cancer Care Program’s Leadership Team and Clinical Trials Committee.  Her areas of interest include breast, genitourinary and head and neck cancer.   

Research Interests:

  • Genitourinary Cancer
  • Breast Cancer
  • Clinical Trials
  • Head and Neck Cancer 


Armstrong et al. Nasopharyngeal Carcinoma in Newfoundland and Labrador: Our 5-year Experience 2002-2007. In press – Oncology Exchange.

Hebbard et al. Cancer Events Associated with Germline Mutations of the CDH1 Gene. Poster Presentation SABCS December 2009.

Haynes et al. Post-chemotherapy arthralgia: A single institution retrospective chart review of breast cancer patients receiving adjuvant chemotherapy. Oncology Exchange 2008.7 (2): 26-29.

Leung et al.  A Case Based Study to Assess the Potential of Carboplatin-Based Synchronous Chemoradiation Therapy to Attain Local Control with Minimal Toxicities for Bladder Cancer Patients Not Candidates for Radical Therapy. Poster Presentation CARO 2006.

Edwards et al. The evaluation and implementation of a process to identify patients eligible for an Aromatase Inhibitor in the adjuvant treatment of post-menopausal hormone sensitive breast cancer patients in Newfoundland and Labrador. Poster Presentation ACOG 2006.

McCarthy et al.  A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral Oncology 2002; 38: 686-690.

Greenland et al. Regulated expression of the retinoblastoma gene product by fibroblast growth factor but not by activin during mesoderm induction in Xenopus. Dev. Genes Evol. 1996; 206:333-336.

Current Appointments:

  • Director of Clinical Trials
  • Cancer Population Accreditation Team
  • Leadership Team Committee
  • Space Planning Committee
  • Chair of Scientific Advisory Committee
  • Cancer Care Program Clinical Trials Committee
  • Co-Chair of Tumour Board Rounds, Cancer Care Program

Professional Affiliations

2011 -- present            Board Member of the Beatrice Hunter Cancer Research Institute
2010 – present            Member of Atlantic Canada Oncology Network.

2009 – present            Board member of Kidney Cancer Canada
2001 – present            Investigator with the NCIC and NCI
2001 – present            Canadian Association of Medical Oncologists
2001 – present            The Newfoundland Medical Board and CMPA
1999 – present            The American Society of Clinical Oncology
1997 – present            Royal College of Physicians and Surgeons of Canada
1992 – present            Canadian Medical Association and NLMA 

Copyright © 2018 Memorial University of Newfoundland.   Newfoundland and Labrador, Canada.